Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Minority Interest: 2020-2025

Historic Minority Interest for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $186.4 million.

  • Maravai Lifesciences Holdings' Minority Interest fell 30.39% to $186.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $186.4 million, marking a year-over-year decrease of 30.39%. This contributed to the annual value of $251.9 million for FY2024, which is 32.49% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Minority Interest stood at $186.4 million for Q3 2025, which was down 7.77% from $202.1 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Minority Interest high stood at $379.1 million for Q1 2023, and its period low was $97.1 million during Q1 2021.
  • Moreover, its 3-year median value for Minority Interest was $337.8 million (2024), whereas its average is $304.1 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Minority Interest soared by 247.04% in 2021 and then crashed by 40.16% in 2025.
  • Maravai Lifesciences Holdings' Minority Interest (Quarterly) stood at $229.9 million in 2021, then surged by 56.63% to $360.0 million in 2022, then increased by 3.64% to $373.1 million in 2023, then crashed by 32.49% to $251.9 million in 2024, then slumped by 30.39% to $186.4 million in 2025.
  • Its last three reported values are $186.4 million in Q3 2025, $202.1 million for Q2 2025, and $229.7 million during Q1 2025.